接种疫苗
2019年冠状病毒病(COVID-19)
CD8型
生物
免疫学
细胞毒性T细胞
病毒载体
免疫系统
医学
病毒学
病理
遗传学
疾病
基因
重组DNA
体外
传染病(医学专业)
作者
Jovana Cupovic,Sandra S. Ring,Lucas Onder,Julia Colston,Mechthild Lütge,Hung‐Wei Cheng,Angelina De Martin,Nicholas M. Provine,Lukas Flatz,Annette Oxenius,Elke Scandella,Philippe Krebs,Daniel Engeler,Paul Klenerman,Burkhard Ludewig
出处
期刊:Nature Immunology
[Nature Portfolio]
日期:2021-07-15
卷期号:22 (8): 1042-1051
被引量:42
标识
DOI:10.1038/s41590-021-00969-3
摘要
Pathogens and vaccines that produce persisting antigens can generate expanded pools of effector memory CD8+ T cells, described as memory inflation. While properties of inflating memory CD8+ T cells have been characterized, the specific cell types and tissue factors responsible for their maintenance remain elusive. Here, we show that clinically applied adenovirus vectors preferentially target fibroblastic stromal cells in cultured human tissues. Moreover, we used cell-type-specific antigen targeting to define critical cells and molecules that sustain long-term antigen presentation and T cell activity after adenovirus vector immunization in mice. While antigen targeting to myeloid cells was insufficient to activate antigen-specific CD8+ T cells, genetic activation of antigen expression in Ccl19-cre-expressing fibroblastic stromal cells induced inflating CD8+ T cells. Local ablation of vector-targeted cells revealed that lung fibroblasts support the protective function and metabolic fitness of inflating memory CD8+ T cells in an interleukin (IL)-33-dependent manner. Collectively, these data define a critical fibroblastic niche that underpins robust protective immunity operating in a clinically important vaccine platform.
科研通智能强力驱动
Strongly Powered by AbleSci AI